Advertisement

Immunogenetics

, Volume 25, Issue 3, pp 200–203 | Cite as

Mouse candidiasis

II. Host responses are T-cell dependent and regulated by genes in the major histocompatibility complex
  • R. B. Ashman
Article

Abstract

Administration of a Thy-1.2-specific monoclonal antibody to BALB/c mice resulted in a significant decrease in the efficiency of clearance of Candida albicans from the spleen. The rate of clearance of organisms from the spleen of congenic mice was determined by genes in the major histocompatibility complex, as was the magnitude of the inflammatory response in the popliteal lymph node after footpad immunization. These results formally demonstrate the involvement of T cells in host responses to primary candida infection.

Keywords

Lymph Node Monoclonal Antibody Inflammatory Response Major Histocompatibility Complex Candida Albicans 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bistoni, F., Marconi, P., Frati, L., Bonmassor, E., and Garaci, E.: Increase of mouse resistance to Candida albicans infection by thymosin α1. Infect. Immun. 36: 609–614, 1982Google Scholar
  2. Bistoni, F., Vecchiarelli, A., Cenci, E., Puccetti, P., Marconi, P., and Cassone, A.: Evidence for macrophage-mediated protection against lethal Candida albicans infection. Infect. Immun. 51: 668–674, 1986Google Scholar
  3. Bodey, G. P.: Candidiasis in cancer patients. Am. J. Med. 2 suppl. 4D: 13–19, 1984Google Scholar
  4. Carrow, E. W. and Domer, J. E.: Immunoregulation in experimental murine candidiasis: Specific suppression induced by Candida albicans cell wall glycoprotein. Infect. Immun. 49: 172–181, 1985Google Scholar
  5. Cheers, C. and Waller, R.: Activated macrophages in congenitally athymic “nude” mice and in lethally irradiated mice. J. Immunol. 115: 844–847, 1975Google Scholar
  6. Clift, R. A.: Candidiasis in the transplant patient. Am. J. Med. 2 (suppl. 4D): 34–38, 1984Google Scholar
  7. Cutler, J. E.: Acute systemic candidiasis in normal and congenitally thymic deficient (nude) mice. J. Reticuloendothel. Soc. 19: 121–126, 1976Google Scholar
  8. Dausset, J. and Svejgaard, A. (eds.): HLA and Disease, p. 1–316, Munksgaard, Copenhagen, 1977Google Scholar
  9. Giger, R. K., Domer, J. E., and McQuitty, J. T., Jr.: Experimental murine candidiasis: Pathological and immune responses to cutaneous inoculation with Candida albicans. Infect. Immun. 19: 499–509, 1978aGoogle Scholar
  10. Giger, D. K., Domer, J. E., Moser, S. A., and McQuitty, J. T., Jr.: Experimental murine candidiasis: Pathological and immune responses in T-lymphocyte-depleted mice. Infect. Immun. 21: 729–737, 1978bGoogle Scholar
  11. Hector, R. F., Domer, J. E., and Carrow, E. W.: Immune responses to Candida albicans in genetically distinct mice. Infect. Immun. 38: 1020–1028, 1982Google Scholar
  12. Hurtrel, B. and Lagrange, P. H.: Dissociation between cell-mediated immunity and acquired resistance in systemic murine candidiasis. Ann. Immunol. (Paris) 136D: 29–36, 1985Google Scholar
  13. Hurtrel, F., Lagrange, P. H., and Michel, A.: Absence of correlation between delayed-type hypersensitivity and protection in experimental systemic candidiasis in immunised mice. Infect. Immun. 31: 95–101, 1981Google Scholar
  14. Kirkpatrick, C. H.: Host factors in defense against fungal infections. Am. J. Med. 2 (suppl. 4D): 1–12, 1984Google Scholar
  15. Ledbetter, J. A. and Herzenberg, L. A.: Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol. Rev. 47: 63–90, 1979Google Scholar
  16. Louria, D. B.: Candida infection in experimental animals In G. P. Bodey and V. Fainstein (eds.): Candidiasis, pp. 29–51, Raven Press, New York, 1985Google Scholar
  17. Maiti, P. K., Kumar, A., Kumar, R., and Mohapatra, L. N.: Role of anti-bodies and effect of BCG vaccination in experimental candidiasis in mice. Mycopathalogica 91: 79–85, 1985Google Scholar
  18. Marra, S. and Balish, E.: Immunity to Candida albicans induced by listeria monocytogenes. Infect. Immun. 10: 72–82, 1974Google Scholar
  19. Miyake, T., Takeyo, K., Nomoto, K., and Muraoka, J.: Cellular elements in the resistance to Candida infection in mice. I. Contribution of T lymphocytes and phagocytes at various stages of infection. Microbiol. Immunol. 21: 703–725, 1977Google Scholar
  20. Odds, F. C.: Candida and Candidosis. University Park Press, Baltimore, 1979Google Scholar
  21. Pearsall, N. N., Adams, B. L., and Bunni, R.: Immunologic responses to Candida albicans. III. Effects of passive transfer of lymphoid cells or serum on murine candidiasis. J. Immunol. 120: 1176–1180, 1978Google Scholar
  22. Rifkind, D., Marchioro, T. L., Schneck, S. A., and Hill, R. B.: Systemic fungal infections complicating renal transplantation and immunosuppressive therapy. Am. J. Med. 43: 28–38, 1967Google Scholar
  23. Rogers, T. J. and Balish, E.: Immunity to Candida albicans. Microbiol. Rev. 44: 660–682, 1980Google Scholar
  24. Rogers, T. J., Balish, E., and Manning, D. D.: The role of thymus-dependent cell-mediated immunity in resistance to experimental disseminated candidiasis. J. Reticuloendothel. Soc. 20: 291–298, 1976Google Scholar
  25. Salvin, S. B., Peterson, R. D. A., and Good, R. A.: The role of the thymus in resistance to infection and endotoxin toxicity. J. Lab. Clin. Med. 65: 1004–1022, 1965Google Scholar
  26. Stenderup, A. and Schonheyder, H.: Mycoses complicating AIDS. Microbiol. Sci. 1: 219–223, 1984Google Scholar
  27. Stobo, J., Hull, S., VanScoy, R., and Hermans, P.: Suppressor thymusderived lymphocytes in fungal infection. J. Clin. Invest. 57: 319–328, 1976Google Scholar
  28. Tabeta, H., Mikami, Y., Abe, F., Ommura, Y., and Arai, T.: Studies on defense mechanisms against Candida albicans infection in congenitally athymic nude (nu/nu) mice. Mycopathologica 84: 107–113, 1984Google Scholar
  29. Wade, J. C. and Schimpff, S. C.: Epidemiology and prevention of candida infections. In G. P. Bodey and V. Fainstein (eds.): Candidiasis, pp. 111–133, Raven Press, New York, 1985Google Scholar
  30. Williams, D., Cook, J., Hoffman, E., and Diluzio, N.: Protective effect of glucan in experimentally induced candidiasis. J. Reticuloendothel. Soc. 23: 479–490, 1978Google Scholar
  31. Zinkernagel, R. M., Leist, T., Hengartner, H., and Althage, A.: Susceptibility to lymphocytic choriomeningitis virus isolates correlates directly with early and high cytotoxic T cell activity, as well as with footpad swelling reaction, and all three are regulated by H-2D. J. Exp. Med. 162: 2125–2141, 1985aGoogle Scholar
  32. Zinkernagel, R. M., Pfau, C. J., Hengartner, H., and Althage, A.: Susceptibility to routine lymphocytic choriomeningitis virus maps to class 1 MHC genes — A model for MHC/disease associations. Nature 316: 814–817, 1985bGoogle Scholar

Copyright information

© Springer-Verlag 1987

Authors and Affiliations

  • R. B. Ashman
    • 1
  1. 1.Clinical Immunology Research UnitPrincess Margaret HospitalSubiacoWestern Australia

Personalised recommendations